IMPAIRED EXTRARENAL DISPOSAL OF AN ACUTE ORAL POTASSIUM LOAD IN PATIENTS WITH END-STAGE RENAL-DISEASE ON CHRONIC-HEMODIALYSIS

被引：0
|
作者：
FERNANDEZ, J
OSTER, JR
PEREZ, GO
机构：
[1] VET ADM MED CTR,MED SERV,DIALYSIS UNIT 111C,MIAMI,FL 33125
[2] VET ADM MED CTR,RES SERV,MIAMI,FL 33125
[3] UNIV MIAMI,SCH MED,DEPT MED,MIAMI,FL 33152
来源：
MINERAL AND ELECTROLYTE METABOLISM | 1986年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 129
页数：5
相关论文
共 50 条
  • [41] HYPERTENSIVE END-STAGE RENAL-DISEASE IN BLACKS - THE ROLE OF END-STAGE RENAL-DISEASE SURVEILLANCE
    MCCLELLAN, W
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 25 - 30
  • [42] HEMODYNAMICS OF HYPERTENSION IN CHRONIC END-STAGE RENAL-DISEASE
    KIM, KE
    SCHWARTZ, AB
    SWARTZ, C
    CHINITZ, JL
    ONESTI, G
    CIRCULATION, 1972, 46 (03) : 456 - +
  • [43] ESSENTIAL SPORADIC OSTEOLYSIS WITH END-STAGE RENAL-DISEASE (ESRD) ON CHRONIC MAINTENANCE HEMODIALYSIS
    NORTHCOOMBES, JD
    KENDRICK, WC
    KIDNEY INTERNATIONAL, 1981, 19 (01) : 134 - 134
  • [44] CONTROL OF SERUM POTASSIUM DURING FASTING IN PATIENTS WITH END-STAGE RENAL-DISEASE
    GIFFORD, JD
    RUTSKY, EA
    KIRK, KA
    MCDANIEL, HG
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 90 - 94
  • [45] MINERALOCORTICOID THERAPY LOWERS SERUM POTASSIUM IN PATIENTS WITH END-STAGE RENAL-DISEASE
    SINGHAL, PC
    DESROCHES, L
    MATTANA, J
    ABRAMOVICI, M
    WAGNER, JD
    MAESAKA, JK
    AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (02) : 138 - 141
  • [46] GASTROINTESTINAL MOTILITY IN PATIENTS WITH END-STAGE RENAL DISEASE ON CHRONIC HEMODIALYSIS
    Broberg, Bo
    Madsen, Jan
    Fuglsang, Stefan
    Holst, Jens
    Christensen, Karl
    Rydahl, Casper
    Idorn, Thomas
    Feldt-Rasmussen, Bo
    Hornum, Mads
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 318 - 318
  • [47] Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis
    Broberg, Bo
    Madsen, Jan L.
    Fuglsang, Stefan
    Holst, Jens J.
    Christensen, Karl Bang
    Rydahl, Casper
    Idorn, Thomas
    Feldt-Rasmussen, Bo
    Hornum, Mads
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31 (04):
  • [48] SINGLE-DOSE PHARMACOKINETICS OF CEFTRIAXONE IN PATIENTS WITH END-STAGE RENAL-DISEASE AND HEMODIALYSIS
    GARCIA, RL
    SANTIVANEZ, V
    BATTILANA, CA
    CHEMOTHERAPY, 1988, 34 (04) : 261 - 266
  • [49] RESULTS OF THE CANADIAN MORBIDITY STUDY IN END-STAGE RENAL-DISEASE PATIENTS TREATED BY HEMODIALYSIS
    CHURCHILL, DN
    SEMINARS IN NEPHROLOGY, 1990, 10 (02) : 66 - 72
  • [50] DECREASED UROPORPHYRINOGEN DECARBOXYLASE ACTIVITY IN PATIENTS WITH END-STAGE RENAL-DISEASE UNDERGOING HEMODIALYSIS
    MAMET, R
    GAFTER, U
    KORZETS, A
    SCHOENFELD, N
    NEPHRON, 1995, 70 (02) : 202 - 206
12345